Silverarc Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Silverarc Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$3.84M	Sell
2022 Q1	$4.36K	Buy
2021 Q4	$11.1M	Buy
2021 Q3	$8.6M	Buy
2021 Q2	$5.5K	Buy
2021 Q1	$3.42M	Buy
2020 Q4	$1.41M	Buy